Blog
A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel
Bryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company...
From Writing a Newspaper Column at Age 7 to Becoming a BioTech CEO
I am always interested in knowing the journey of how a person ended up where they are. Successes, failures, and everything in between. What drives this curiosity in me is the desire to not just "hear" but "understand" a person to learn from them and seek to apply...
Biotech Chief People Officer Discusses How To Build Company Culture
Science will only get you so far in biotech. No matter how ingenious your products are, you will never succeed as a company if you don’t have all the pieces if business development in place. And there is no greater piece than the people piece. As the Chief...
Qualigen Therapeutics: Where It All Started And Where It’s Going With Founder And CEO Michael Poirier
In this episode of BioTech IQ, Ammon Rivera continues his exploration of Qualigen Therapeutics by interviewing the founder and CEO of the company Michael Porier. Michael discusses how Qualigen was started and the motivation behind the therapeutics pipeline....
Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO’s Perspective With Tariq Arshad, MD
There isn’t a cure for cancer yet, but if everyone can come together, we may find that cure sooner rather than later. One biotech company that is trying to solve cancer is Qualigen Therapeutics. With their oncology therapeutics pipeline, they could be onto...
Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick
Qualigen Therapeutics is a biotechnology company that develops novel therapeutic products to treat adult and pediatric patients with rare cancers. A leading name in the industry, they have decided to build a therapeutics pipeline within the last few years. In...
Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon
AI has gone so far as to potentially change drug development, and these developments have the potential to make a difference in people’s lives. On this episode of BioTech IQ, Ammon interviews Noam Solomon, the CEO of Immunai. Immunai is developing an AI...
Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh
Social anxiety disorder is the third most common mental health disorder. Over 23 million Americans alone are affected by it. This disorder can continue to grow into depression and drug abuse, so it's very important to catch it early so it can be stopped. But...
Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper
Companies in the biotech space are making contributions to help find a cure for cancer. Today’s guest is no exception. In today’s episode, Ammon Rivera sits down with Daniel Teper, Co-Founder and CEO of Cytovia Therapeutics, to talk about the unique technology...
Need help with recruiting or filling a position? Let us know.